Nrf2 has been extensively studied in bladder as a defender against tobacco carcinogens [35, 36]; conversely, Nrf2 may also protect bladder cancer cells against reactive oxygen species and promote resistance to chemotherapeutic agents [37, 38]. The gene discussed is NFE2L2; the disease is urinary bladder cancer.